C7C-13109-31467
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 928 / CA
- Registered
- 2022-07-08
- Relationship
- Child or adolescent in my care
- Guardian
- YG7-18382-23707
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-08
Registered in v-safe
-
2022-07-08
Dose 1 — Moderna
-
2022-07-08
Health check-in — day 0, dose 1, dependentFeeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-07-09
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fever · Fatigue or tirednessAdult check-in
-
2022-07-10
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fever · Fatigue or tirednessAdult check-in
- 2022-07-11
- 2022-07-12
- 2022-07-13
- 2022-07-14
- 2022-07-15
- 2022-07-22
- 2022-07-31
-
2022-08-05
Dose 2 — Moderna
- 2022-08-07
- 2022-08-08
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-20
- 2022-08-26
- 2022-09-02
- 2022-09-09
- 2022-09-16
-
2022-11-07
Survey response — 3 months, dose 2, dependentMedDRA: Asthenia, Pyrexia, Respiratory symptom, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever 102-104 for 10 days, respiratory infection symptoms (congestion, runny nose), low energyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Report sent to call center — 3 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-08 | Moderna | No |
| 2 | 2022-08-05 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-07 | Successful 2022-11-08 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 — 3 months, dose 2, dependent
Symptoms: Fever 102-104 for 10 days, respiratory infection symptoms (congestion, runny nose), low energy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release